CLINICAL RESEARCH

PHARMACEUTICAL & MEDICAL DEVICE

As a niche service clinical research provider to the pharmaceutical and medical devices industries, IMCC is privileged to have worked for both pharmaceutical and medical device environment, as well as for Clinical Research Organizations, as directly for pharmaceutical and medical device companies, to achieve their goals in terms of monitoring and managing Investigational Sites according to ICH-GCP regulations.

With experiences in the fourth trial phases, timelines and goals will be consistently met. Thanks to our integrity, responsibility, quality and accuracy at work, we provide you the best services in accordance to your requirements. 

Phase 1

In Phase 1, an experimental medicine is administered, for the first time, to humans. Phase 1 clinical trials usually focus on safety and tolerability, rather than the effectiveness of a new medicine.

Phase 2

In Phase 2, the focus of the trials is on the effectiveness of an experimental medicine in treating an illness or medical condition. Information about the experimental medicine's safety, side effects, and potential risks is also collected. In this phase, researchers work to determine the most effective dosages for the experimental medicine and the most appropriate method of delivering it.

Phase 3

Phase 3 trials test the results of earlier trials in larger populations and gather additional information about the effectiveness and safety of an experimental medicine. This phase will usually involve several hundred to several thousand participants from multiple sites with many physician-investigators. These trials are often randomized and "double-blinded." Phase 4

Phase 4

Phase 4 trials are conducted after the regulatory approval of a medicine. Through such trials, researchers collect additional information about long-term risks, benefits, and optimal use. These trials often involve thousands of subjects and may continue for many years.